title: pH stability and comparative evaluation of ranaspumin-2 foam for application in biochemical reactors.
abstract: Aqueous channels of foam represent a simplified, natural bioreactor on the micro-/nano-scale. Previous studies have demonstrated the feasibility and potential application of foams in replicating cellular process in vitro, but no research has been performed to establish a basis for designing stable and biocompatible foam formulations. Our research has been directed specifically to the evaluation of ranaspumin-2 (RSN-2), a frog foam nest protein. The strong surfactant activity of RSN-2 enabled us to produce foams using low protein concentration (1 mg ml(-1)) over a wide pH range (pH ≥ 3). Importantly, the RSN-2 formulation exhibited the best foam stability at a near neutral pH condition, which shows a potential for application to various biosynthesis applications. Model cellular systems such as liposomes and inactivated A/PR/8/34 influenza virus maintained their physicochemical stability and full hemagglutination activity, indicating biocompatibility of RSN-2 with both cellular membranes and proteins both in bulk solution and in foam. Moreover, the addition of RSN-2 did not exert any deteriorative effects on bacterial cell growth kinetics. In contrast, Tween 20, Triton X-100, and BSA did not show satisfactory performance in terms of foamability, foam stability, physicochemcial stability, and biochemical stability. Although our study has been limited to representative formulations composed of only surfactant molecules, a number of unique advantages make RSN-2 a promising candidate for in vitro foam biosynthesis.
authors: School of Energy, Environmental, Biological and Medical Engineering, University of Cincinnati, Cincinnati, OH 45221, USA. choihc@ucmail.uc.edu
authors: Hyo-Jick
authors: HJ
authors: Choi
authors: Charles F
authors: CF
authors: Ebersbacher
authors: Fu-Shi
authors: FS
authors: Quan
authors: Carlo D
authors: CD
authors: Montemagno
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology; D019149:Bioreactors; D004285:Dogs; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D006384:Hemagglutination / Q000187:drug effects; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D009980:Influenza A virus / Q000187:drug effects / Q000648:ultrastructure; D008081:Liposomes / Q000737:chemistry; D061985:Madin Darby Canine Kidney Cells; D011487:Protein Conformation; D055550:Protein Stability / Q000187:drug effects; D011506:Proteins / Q000737:chemistry / Q000494:pharmacology*; D013050:Spectrometry, Fluorescence; D013501:Surface-Active Agents / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D001672:Biocompatible Materials; D008081:Liposomes; D011506:Proteins; D013501:Surface-Active Agents